Literature DB >> 6386665

Reversal by interleukin-2 of the T cell unresponsiveness of lepromatous leprosy to Mycobacterium leprae.

A Haregewoin, A S Mustafa, I Helle, M F Waters, D L Leiker, T Godal.   

Abstract

In some subjects Mycobacterium leprae causes disseminated (lepromatous) disease. Such subjects show both in vivo and in vitro deficient T cell responses to M. leprae, but not to other antigens. We have recently shown that lepromatous peripheral blood mononuclear cells (PBMC) failed to produce interleukin 2 (IL-2) in response to M. leprae and that T cell-conditioned media (TCM) can reverse the T cell unresponsiveness in a majority of lepromatous leprosy patients (Haregewoin et al. 1983). Here we show that highly purified and recombinant IL-2 had effects similar to TCM. On the other hand, lepromatous PBMC produced IL-1, and IL-1 had no restorative effect. These findings provide further evidence that the unresponsiveness in lepromatous leprosy often results from a deficiency in IL-2 production. After initial stimulation with TCM + M. leprae, lepromatous PBMC could be restimulated with M. leprae alone, providing clear evidence that M. leprae-reactive lymphocytes were generated in the presence of TCM. The present findings are discussed in relation to the possible mechanisms involved in the failure of IL-2 production. If our findings can be reproduced in vivo, IL-2 may offer a novel approach to therapy in lepromatous leprosy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386665     DOI: 10.1111/j.1600-065x.1984.tb00495.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  12 in total

Review 1.  Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients.

Authors:  C Cocito; J Delville
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

2.  Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin.

Authors:  S Barnass; J Mace; J Steele; P Torres; B Gervasoni; R Ravioli; J Terencio; G A Rook; M F Waters
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

3.  Limiting dilution analysis of T cell unresponsiveness to mycobacteria in advanced disseminated tuberculosis.

Authors:  M S Gilardini Montani; F Del Gallo; G Lombardi; P Del Porto; E Piccolella; F Arienzo; V Colizzi
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

4.  T-cell-mediated cytotoxicity against Mycobacterium antigen-pulsed autologous macrophages in leprosy patients.

Authors:  M C Sasiain; S de la Barrera; F Minnucci; R Valdez; M M de Elizalde de Bracco; L M Baliña
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

5.  Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation.

Authors:  T J Holzer; K E Nelson; R G Crispen; B R Andersen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

Review 6.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

7.  Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae.

Authors:  L D Sibley; J L Krahenbuhl
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

8.  Evidence of cell-mediated immune contrasuppression in lepromatous leprosy: modulation of a putative T contrasuppressor cell-subset.

Authors:  R González-Amaro; J F Salazar-González; L Baranda; C Abud-Mendoza; B Moncada; R García; J Alcocer-Varela
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

9.  Mycobacterium leprae actively modulates the cytokine response in naive human monocytes.

Authors:  Daniel Sinsimer; Dorothy Fallows; Blas Peixoto; James Krahenbuhl; Gilla Kaplan; Claudia Manca
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

10.  Recombinant interleukin-2 limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice.

Authors:  A Jeevan; G L Asherson
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.